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Abstract
The aim of our paper is to describe an unusual pulmonary toxicity of sirolimus (SRL) in a kidney 
transplant recipient. We present a 34-year-old woman with a second renal transplantation, complicated 
with steroid-resistant acute rejection and chronic allograft dysfunction. Two years after initiating SRL, 
she presented complaints of progressive dyspnoea, nonproductive cough, chest pain and low-grade fever 
of 1 month duration. She had chronic allograft nephropathy and slight elevation of lactic dehydrogenase 
levels. After exclusion of common reasons of this condition, a computed tomography (CT) of the thorax 
and bronchoscopy was performed, revealing ground-glass opacification with polygonal shapes on CT 
and an opaque appearance with numerous macrophages on bronchoalveolar lavage. The alveolar 
macrophages stained positive by Periodic acid-Schiff. Diagnosis of pulmonary alveolar proteinosis 
(PAP) was made and drug-induced toxicity was suspected. SRL was withdrawn with marked 
improvement in the patients' clinical and radiological status. PAP resolved within 3 months without 
further therapy. PAP is a very rare complication of SRL therapy with only a few cases described. 
Withdrawal of SRL with conversion to another immunosuppressant seems to be an appropriate 
procedure in this condition.
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